Skip to main content
Erschienen in: Clinical Rheumatology 6/2015

01.06.2015 | Original Article

Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus

verfasst von: Arezou Rezaei, Vahid Ziaee, Fatemeh Tahghighi Sharabian, Sara Harsini, Maryam Mahmoudi, Samaneh Soltani, Maryam Sadr, Mohammad Hassan Moradinejad, Yahya Aghighi, Nima Rezaei

Erschienen in: Clinical Rheumatology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

As abundant types of genetic predisposition and environmental factors seem to be associated with the development of juvenile-onset systemic lupus erythematosus (JSLE), we investigated the gene polymorphisms of two anti-inflammatory cytokines, including interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which were previously found to be associated with SLE in adults, in a group of patients with JSLE. We studied a group of 59 Iranian patients with JSLE in comparison with 140 healthy controls and assessed the frequency of alleles, genotypes, and haplotypes of IL-10 and TGF-β single-nucleotide polymorphisms (SNPs) using polymerase chain reaction with sequence-specific primers method. The CA genotype was significantly more frequent at position −592 in IL-10 in patients with juvenile-onset systemic lupus erythematosus than in the controls (P = 0.01). Genotype CC was detected at the same position in 32.7 % of the patients; this frequency was significantly lower than the frequency of 50.7 % recorded in the healthy controls (P = 0.03). The TC haplotype of TGF-β (codon 10, codon 25) was significantly more frequent in the patients with juvenile-onset systemic lupus erythematosus than in the healthy controls (P = 0.02). Nevertheless, these significant associations disappear after Bonferroni correction. Our findings suggest that IL-10 (−1082, −819, −592) and TGF-β (codon 10, codon 25) gene variants may not be associated with the development of JSLE in Iranian population.
Literatur
1.
Zurück zum Zitat Yap DYH, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrol 18:243–255CrossRef Yap DYH, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrol 18:243–255CrossRef
2.
Zurück zum Zitat Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561–577CrossRef Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561–577CrossRef
3.
Zurück zum Zitat Tucker L, Menon S, Schaller J, Isenberg D (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology 34:866–872CrossRef Tucker L, Menon S, Schaller J, Isenberg D (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology 34:866–872CrossRef
4.
Zurück zum Zitat Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L (2007) Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology 46:1290–1296CrossRefPubMed Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L (2007) Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology 46:1290–1296CrossRefPubMed
6.
Zurück zum Zitat Costallat L, Coimbra A (1993) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607 Costallat L, Coimbra A (1993) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607
7.
Zurück zum Zitat Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513–521CrossRefPubMed Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513–521CrossRefPubMed
8.
9.
Zurück zum Zitat Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146CrossRefPubMed Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146CrossRefPubMed
10.
Zurück zum Zitat Su D-L, Lu Z-M, Shen M-N, Li X, Sun L-Y (2012) Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. BioMed Research International 2012 Su D-L, Lu Z-M, Shen M-N, Li X, Sun L-Y (2012) Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. BioMed Research International 2012
11.
Zurück zum Zitat Park Y, Lee S, Kim D, Lee J, Lee C, Song C (1997) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283–288 Park Y, Lee S, Kim D, Lee J, Lee C, Song C (1997) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283–288
12.
Zurück zum Zitat Miyake K, Nakashima H, Akahoshi M et al (2002) Genetically determined interferon‐γ production influences the histological phenotype of lupus nephritis. Rheumatology 41:518–524CrossRefPubMed Miyake K, Nakashima H, Akahoshi M et al (2002) Genetically determined interferon‐γ production influences the histological phenotype of lupus nephritis. Rheumatology 41:518–524CrossRefPubMed
13.
Zurück zum Zitat Ohtsuka K, Gray J, Stimmler M, Horwitz D (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8:90–94CrossRefPubMed Ohtsuka K, Gray J, Stimmler M, Horwitz D (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8:90–94CrossRefPubMed
14.
Zurück zum Zitat Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922CrossRefPubMed Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922CrossRefPubMed
15.
Zurück zum Zitat Rood M, Van Krugten M, Zanelli E et al (2000) TNF‐308A and HLA–DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134CrossRefPubMed Rood M, Van Krugten M, Zanelli E et al (2000) TNF‐308A and HLA–DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134CrossRefPubMed
16.
Zurück zum Zitat Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 21:292–296PubMed Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 21:292–296PubMed
17.
Zurück zum Zitat Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M (2009) Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29:57–62CrossRefPubMed Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M (2009) Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29:57–62CrossRefPubMed
18.
Zurück zum Zitat Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27CrossRefPubMedCentralPubMed Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Amirzargar AA, Bagheri M, Ghavamzadeh A et al (2005) Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32:167–171CrossRefPubMed Amirzargar AA, Bagheri M, Ghavamzadeh A et al (2005) Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32:167–171CrossRefPubMed
20.
Zurück zum Zitat Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89PubMed Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89PubMed
21.
Zurück zum Zitat Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed
22.
Zurück zum Zitat Mahmoudi M, Tahghighi F, Ziaee V et al (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed Mahmoudi M, Tahghighi F, Ziaee V et al (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed
23.
Zurück zum Zitat Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24:11–13CrossRefPubMed Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24:11–13CrossRefPubMed
24.
Zurück zum Zitat da Silva HDA, da Silva AP, da Silva HA, Asano NMJ, Maia MdMD, de Souza PRE (2014) Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus. Molecular biology reports 1–8 da Silva HDA, da Silva AP, da Silva HA, Asano NMJ, Maia MdMD, de Souza PRE (2014) Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus. Molecular biology reports 1–8
25.
Zurück zum Zitat Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K (2013) Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus 22:721–726CrossRefPubMed Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K (2013) Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus 22:721–726CrossRefPubMed
26.
Zurück zum Zitat Chong W, Ip W, Wong WH, Lau C, Chan T, Lau Y (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484–492CrossRefPubMed Chong W, Ip W, Wong WH, Lau C, Chan T, Lau Y (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484–492CrossRefPubMed
27.
Zurück zum Zitat Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed
28.
Zurück zum Zitat Giordano M, Mellai M, Lanceni M et al (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454–463CrossRefPubMed Giordano M, Mellai M, Lanceni M et al (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454–463CrossRefPubMed
29.
Zurück zum Zitat Dijstelbloem HM, Hepkema BG, Kallenberg CG et al (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125–1126CrossRefPubMed Dijstelbloem HM, Hepkema BG, Kallenberg CG et al (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125–1126CrossRefPubMed
30.
Zurück zum Zitat Schotte H, Willeke P, Rust S et al (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed Schotte H, Willeke P, Rust S et al (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed
31.
Zurück zum Zitat Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto H, Kumagai S (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53:15–23PubMed Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto H, Kumagai S (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53:15–23PubMed
32.
Zurück zum Zitat Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect = Wei Mian yu gan ran za zhi 37:145–152 Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect = Wei Mian yu gan ran za zhi 37:145–152
33.
Zurück zum Zitat Amirzargar AA, Naroueynejad M, Khosravi F et al (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed Amirzargar AA, Naroueynejad M, Khosravi F et al (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed
34.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725CrossRefPubMed
35.
36.
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289–300
37.
Zurück zum Zitat Hoffmann SC, Stanley EM, Cox ED et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 72:1444–1450CrossRefPubMed Hoffmann SC, Stanley EM, Cox ED et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 72:1444–1450CrossRefPubMed
38.
Zurück zum Zitat Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β*. Annu Rev Immunol 16:137–161CrossRefPubMed Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β*. Annu Rev Immunol 16:137–161CrossRefPubMed
39.
Zurück zum Zitat Wahl SM (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180:1587–1590CrossRefPubMed Wahl SM (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180:1587–1590CrossRefPubMed
40.
Zurück zum Zitat Huggins M, Todd I, Cavers M, Pavuluri S, Tighe P, Powell R (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322CrossRefPubMedCentralPubMed Huggins M, Todd I, Cavers M, Pavuluri S, Tighe P, Powell R (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322CrossRefPubMedCentralPubMed
41.
Zurück zum Zitat Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Inv 101:890CrossRef Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Inv 101:890CrossRef
42.
Zurück zum Zitat Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97CrossRefPubMed Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97CrossRefPubMed
43.
Zurück zum Zitat Guarnizo Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70:376–382CrossRefPubMed Guarnizo Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70:376–382CrossRefPubMed
44.
Zurück zum Zitat Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26PubMed Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26PubMed
45.
Zurück zum Zitat de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220CrossRef de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220CrossRef
46.
Zurück zum Zitat Rousset F, Garcia E, Defrance T et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 89:1890–1893CrossRefPubMedCentralPubMed Rousset F, Garcia E, Defrance T et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 89:1890–1893CrossRefPubMedCentralPubMed
47.
Zurück zum Zitat Levy Y, Brouet J-C (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Inv 93:424CrossRef Levy Y, Brouet J-C (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Inv 93:424CrossRef
48.
Zurück zum Zitat Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet : Off J Br Soc Histocompatibility Immunogenet 24:1–8CrossRef Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet : Off J Br Soc Histocompatibility Immunogenet 24:1–8CrossRef
49.
Zurück zum Zitat Kindt S, Van Oudenhove L, Broekaert D et al (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil : Off J Eur Gastrointest Motil Soc 21:389–398CrossRef Kindt S, Van Oudenhove L, Broekaert D et al (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil : Off J Eur Gastrointest Motil Soc 21:389–398CrossRef
50.
Zurück zum Zitat Hua MC, Chao HC, Yao TC, Lai MW, Huang JL (2013) Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7:430–436CrossRefPubMedCentralPubMed Hua MC, Chao HC, Yao TC, Lai MW, Huang JL (2013) Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7:430–436CrossRefPubMedCentralPubMed
51.
Zurück zum Zitat Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64:1605–1610CrossRefPubMedCentralPubMed Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64:1605–1610CrossRefPubMedCentralPubMed
52.
Zurück zum Zitat Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin‐10 5′ flanking region are not associated with renal disease or serology in caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017–2018CrossRefPubMed Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin‐10 5′ flanking region are not associated with renal disease or serology in caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017–2018CrossRefPubMed
53.
Zurück zum Zitat Lazarus M, Hajeer A, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317PubMed Lazarus M, Hajeer A, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317PubMed
54.
Zurück zum Zitat Sung Y-K, Park B, Shin H, Kim L, Kim S-Y, Bae S-C (2006) Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology 45:400–404CrossRefPubMed Sung Y-K, Park B, Shin H, Kim L, Kim S-Y, Bae S-C (2006) Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology 45:400–404CrossRefPubMed
55.
Zurück zum Zitat Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin‐10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68:399–406CrossRefPubMed Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin‐10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68:399–406CrossRefPubMed
56.
Zurück zum Zitat Lin Y, Wan L, Huang C et al (2010) L-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28:318–324PubMed Lin Y, Wan L, Huang C et al (2010) L-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28:318–324PubMed
57.
Zurück zum Zitat Rosado S, Rua-Figueroa I, Vargas J et al (2008) Interleukin‐10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35:235–242CrossRefPubMed Rosado S, Rua-Figueroa I, Vargas J et al (2008) Interleukin‐10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35:235–242CrossRefPubMed
Metadaten
Titel
Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus
verfasst von
Arezou Rezaei
Vahid Ziaee
Fatemeh Tahghighi Sharabian
Sara Harsini
Maryam Mahmoudi
Samaneh Soltani
Maryam Sadr
Mohammad Hassan Moradinejad
Yahya Aghighi
Nima Rezaei
Publikationsdatum
01.06.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 6/2015
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2877-2

Weitere Artikel der Ausgabe 6/2015

Clinical Rheumatology 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.